Brzezińska E
Institute of Chemistry and Technology of Drugs, School of Medicine, Lódź, Poland.
Acta Pol Pharm. 1994;51(2):137-41.
The new derivatives of 1,2,3,4-tetrahydroisoquinoline-4,6,8-triol were synthesized as a potential beta-adrenergic blockers. These compounds were obtained by simple modification of beta-adrenergic agonists (terbutaline, orciprenaline, fenoterole) and evaluated pharmacologically for their activity and binding to beta-adrenoreceptor.
合成了1,2,3,4-四氢异喹啉-4,6,8-三醇的新衍生物作为潜在的β-肾上腺素能阻滞剂。这些化合物通过对β-肾上腺素能激动剂(特布他林、奥西那林、非诺特罗)进行简单修饰而获得,并对其活性及与β-肾上腺素受体的结合进行了药理学评估。